Hepatitis A - hepatitis B new generation vaccine - Sinovac Biotech
Latest Information Update: 23 Aug 2023
At a glance
- Originator Sinovac Biotech
- Class Hepatitis A vaccines; Hepatitis B vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Hepatitis A; Hepatitis B
Most Recent Events
- 28 Jan 2019 No recent reports of development identified for preclinical development in Hepatitis-A(Prevention) in China (Parenteral)
- 28 Jan 2019 No recent reports of development identified for preclinical development in Hepatitis-B(Prevention) in China (Parenteral)
- 31 Dec 2014 Sinovac Biotech submits Clinical Trial Application to China FDA for Hepatitis A and Hepatitis B infections (Prevention)